Refine
Year of publication
Has Fulltext
- yes (71)
Is part of the Bibliography
- no (71)
Keywords
- autophagy (8)
- glioblastoma (5)
- apoptosis (3)
- cell biology (3)
- phosphorylation (3)
- ubiquitin (3)
- ubiquitination (3)
- Autophagy (2)
- BAG3 (2)
- Biochemistry (2)
- Cell biology (2)
- USP28 (2)
- Ubiquitylation (2)
- aging (2)
- c-MYC (2)
- cell death (2)
- cell migration (2)
- epithelial to mesenchymal transition (2)
- human (2)
- inflammation (2)
- lung cancer (2)
- mouse (2)
- oligomerisation (2)
- primary cilium (2)
- receptor (2)
- triple-negative breast cancer (2)
- 3Cs technology (1)
- AML – acute myeloid leukemia (1)
- AMPK (1)
- ATG4 (1)
- ATG8 (1)
- BRAF (1)
- BRD4 (1)
- BRD4-NUT (1)
- Bag6 (1)
- Biological Activity (1)
- Buparlisib (1)
- C. elegans (1)
- Calnexin (1)
- Cancer (1)
- Conventional and unconventional ubiquitination (1)
- Crispr/Cas (1)
- DNA damage (1)
- DNA replication (1)
- DNA-protein crosslinks (1)
- DUBs (1)
- Doxorubicin (1)
- Drug Discovery (1)
- Dvc1 (1)
- E. coli (1)
- E3-Ligases (1)
- EGFR (1)
- Endoplasmic reticulum (1)
- FAM134B (1)
- Feasibility (1)
- Fluorescent Probes (1)
- G9a/EHMT2/KMT1C (1)
- HRAS 28 Gefitinib (1)
- Hedgehog (1)
- Immunology (1)
- KCGS (1)
- LAMTOR1 (1)
- LC3/GABARAP (1)
- LC3B (1)
- LIR (1)
- LIR interaction, (1)
- LPS (1)
- LUBAC (1)
- Legionella pneumophila (1)
- Manatee invariant (1)
- Mathematical model (1)
- Microbiology (1)
- Mislocalised proteins (1)
- Mitophagy (1)
- NF-κB (1)
- NF-κB pathway (1)
- Notch (1)
- PIK3CA (1)
- Pathogens (1)
- Petri net (1)
- Phosphorylation (1)
- Profiling Transthiolation Activity (1)
- Proteasomes (1)
- Protein Structure (1)
- Protein degradation (1)
- Protein-Protein Interactions (1)
- ROS (1)
- RUFY (1)
- Rab7 (1)
- Ragulator complex (1)
- Research article (1)
- Reticulon (1)
- Rtn3 (1)
- Ruijs-Aalfs syndrome (1)
- S. cerevisiae (1)
- SARS-CoV-2 (1)
- SIRT1 (1)
- SPARTAN (1)
- SPRTN (1)
- Selective autophagy (1)
- Sharpin (1)
- Signal Transduction (1)
- Signaling pathway (1)
- Skp (1)
- TAX1BP1 (1)
- TBK1 (1)
- TNFR1 (1)
- TPR (1)
- Tools and ressources (1)
- Topoisomerase (1)
- Transition invariant (1)
- UBA5 (1)
- UFIM (1)
- UFM1 (1)
- USP32 (1)
- Ubiquitin Ligase (1)
- Ubiquitin signaling (1)
- Ubiquitin-binding module (1)
- Ubiquitination (1)
- Vemurafenib (1)
- WRNIP1 (1)
- X-ray Crystallography (1)
- alveolar macrophages (1)
- antiviral signaling (1)
- astrocytoma (1)
- bacteria (1)
- biochemistry (1)
- buparlisib (1)
- c-JUN (1)
- c1orf124 (1)
- calcitriol (1)
- cancer (1)
- cancer stem cells (1)
- chemogenomic set (1)
- collagen (1)
- cytarabin (1)
- deubiquitinase (DUB) (1)
- differentiation (1)
- drug discovery (1)
- druggable genome (1)
- endoplasmic reticulum (1)
- famotidine (1)
- fasting (1)
- gRNA library (1)
- gefitinib (1)
- genetics and genomics (1)
- genome-wide (1)
- glioblastoma stem-like cells (1)
- green fluorescent protein (1)
- hMOF/KAT8 (1)
- histamine (1)
- immunology (1)
- inhibitors (1)
- innate immunity (1)
- isothermal titration calorimetry (ITC) (1)
- kinase inhibitor (1)
- life span (1)
- lysosomes (1)
- mTORC1 (1)
- metabolic syndromes (1)
- metabolism (1)
- metalloprotease (1)
- mitochondrial metabolism (1)
- mitochondrial morphology (1)
- mitophagy (1)
- neurodegeneration (1)
- novel technologies (1)
- nuclear hormone receptor (1)
- nuclear magnetic resonance (NMR) (1)
- phage display (1)
- phenotypic screening (1)
- pol g (1)
- progeria (1)
- protein kinase (1)
- protein motif (1)
- selective autophagy (1)
- selective autophagy receptor (1)
- short linear motifs (SLiMs) (1)
- signal transduction (1)
- skin inflammation (1)
- small molecules (1)
- stress response (1)
- teratoma (1)
- toll-like receptor (1)
- transcriptional regulation of autophagy (1)
- ubiquitin-binding zinc finger (1)
- understudied kinase (1)
- v-ATPase (1)
- vemurafenib (1)
- viruses (1)
- vitamin D3 (1)
- x-ray crystallography (1)
Institute
- Medizin (60)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (19)
- Exzellenzcluster Makromolekulare Komplexe (14)
- Biochemie und Chemie (11)
- Biochemie, Chemie und Pharmazie (5)
- Biowissenschaften (4)
- MPI für Biophysik (4)
- Physik (3)
- Informatik (2)
- Biodiversität und Klima Forschungszentrum (BiK-F) (1)
Oncogenic transformation of lung epithelial cells is a multistep process, frequently starting with the inactivation of tumour suppressors and subsequent development of activating mutations in proto-oncogenes, such as members of the PI3K or MAPK families. Cells undergoing transformation have to adjust to changes, including altered metabolic requirements. This is achieved, in part, by modulating the protein abundance of transcription factors. Here, we report that the ubiquitin carboxyl-terminal hydrolase 28 (USP28) enables oncogenic reprogramming by regulating the protein abundance of proto-oncogenes such as c-JUN, c-MYC, NOTCH and ∆NP63 at early stages of malignant transformation. USP28 levels are increased in cancer compared with in normal cells due to a feed-forward loop, driven by increased amounts of oncogenic transcription factors such as c-MYC and c-JUN. Irrespective of oncogenic driver, interference with USP28 abundance or activity suppresses growth and survival of transformed lung cells. Furthermore, inhibition of USP28 via a small-molecule inhibitor resets the proteome of transformed cells towards a ‘premalignant’ state, and its inhibition synergizes with clinically established compounds used to target EGFRL858R-, BRAFV600E- or PI3KH1047R-driven tumour cells. Targeting USP28 protein abundance at an early stage via inhibition of its activity is therefore a feasible strategy for the treatment of early-stage lung tumours, and the observed synergism with current standard-of-care inhibitors holds the potential for improved targeting of established tumours.